Fellowship Associate Program Director, Fellowship Endoscopy Training Director, Baltimore VA Medical Center IBD Clinic Director, Gastroenterology Clerkship Course Director
Education and Training
Dr. Wong completed her medical training at the University of Vermont College of Medicine in 2010. She completed residency training in Internal Medicine and fellowship training in Gastroenterology (with a focus on Inflammatory Bowel Diseases) at the University of Maryland Medical Center. She joined faculty at the University of Maryland School of Medicine in 2017.
Inflammatory bowel disease (IBD), Clinical outcomes research, Response to therapy.
Wong U and Cross RK. Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease. Expert Opin Investig Drugs. 2019 Mar 18:1-7.
Wong U, Person EB, Castell DO, et al. Improving High-resolution Impedance Manometry Using Novel Viscous and Super-viscous Substrates in the Supine and Upright Positions: A Pilot Study. J Neurogastroenterol Motil. 2018 Oct 1;24(4):570-576.
Wong U and Cross RK. Primary and secondary nonresponse to infliximab: mechanisms and countermeasures. Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1039-1046.
Wong U, Yfantis H, and Xie G. Urticarial Vasculitis-Associated Intestinal Ischemia. Case Rep Gastrointest Med. 2016; 2016:8603679. Epub 2016 Apr 17.
Wong U and Darwin P. Appendiceal mucocele diagnosed in patients with inflammatory bowel disease using endoscopic ultrasound. Case Rep Med. 2012;2012:849892. Epub 2012 Jul 3.
Wong U and Raufman JP. Esophageal infections, In Clinical Infectious Diseases, Third Edition. (In Press).
Wong U and Cross RK. Noninfectious and nonmalignant complications of anti-TNF therapy, In: Treatment of Inflammatory Bowel Disease with Biologics. Springer International Publishing, Chapter 14, 2018.